Seres Therapeutics Inc (MCRB) Earnings Report - Forecasts and Surprise Ratio

Quarterly Earnings History

MCRB ratio: 54%

100%

MCRB beat 19 of 35 last estimates

Date of next report: Mar 4, 2025

Estimate for Q4 24: $-0.18

Implied change from Q3 24: -45.45%

Implied change from Q4 23: -43.75%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q3 24	Nov 13, 2024	$-0.33 / $-0.25	$-0.08 / -32%
Q2 24	Aug 13, 2024	$-0.22 / $-0.28	$0.06 / 21.43%
Q1 24	May 8, 2024	$-0.27 / $-0.36	$0.09 / 25%
Q4 23	Mar 5, 2024	$-0.32 / $-0.4	$0.08 / 20%
Q3 23	Nov 2, 2023	$-0.37 / $-0.47	$0.1 / 21.28%
Q2 23	Aug 8, 2023	$0.36 / $0.55	$-0.19 / -34.55%
Q1 23	May 9, 2023	$-0.57 / $-0.57	$0 / -
Q4 22	Mar 7, 2023	$-0.54 / $-0.41	$-0.13 / -31.71%

Data Vendor: Xignite Logo